JD, MEITUAN Commence Online Payment Test for OTC Drugs in Beijing

In order to further satisfy the public's demand for convenient healthcare services and to facilitate the online purchase of medicines by its insured members using their individual health insurance accounts, the National Healthcare Security Administration (NHSA) of Beijing is organizing two drug-purchasing platforms, JD-SW (09618.HK)  -0.800 (-0.669%)    Short selling $190.46M; Ratio 14.580%   (JD.US)      and MEITUAN-W (03690.HK)  +2.400 (+2.064%)    Short selling $362.43M; Ratio 14.437%   , to start testing the online payment system for over-the-counter (OTC) medicines, and is aiming to start formally providing the service to insured members after connecting to more than 200 designated retail pharmacies under the health insurance scheme from July.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2024-05-27 16:25.) (Real-time Streaming US Stocks Quote; Except All OTC quotes are at least 15 minutes delayed.)